Insights On Trial Design

  1. The "Unique" Opportunity Presented by Southeast Asia 2/26/2025

    Southeast Asia has emerged as a pivotal region for vaccine clinical trials, driven by rapid recruitment, cost efficiency, and robust immunization infrastructure.

  2. Real-World Data Has Real Impact On Clinical Research 9/18/2025

    The ultimate goal of using real-world data (RWD) in clinical research is to ensure a patient is on the right therapy and receiving the right care at the right point in their healthcare journey.

  3. Avoid Database Go-Live Delays With The Right EDC System 10/4/2024

    If you are looking to speed up your start-up process, selecting a reliable EDC System is key.

  4. Beyond The Benchmark: Innovative Trial Designs Transform Research 1/15/2026

    Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.

  5. Practical Strategies For Diverse Trial Recruitment 11/11/2024

    The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.

  6. Myasthenia Gravis: Reducing Outcome Measures Variability In Trials 7/16/2024

    Myasthenia Gravis is a rare autoimmune disease often unknown to the public. This post explores MG's history, treatment progress, clinical trial challenges, and strategies to reduce outcome variability, improving patient care.

  7. Enrollment And Retention: Applying Corporate Meetings Management Best Practices 12/8/2025

    Discover how a structured, scalable approach to patient support can streamline trial operations, improve retention, and elevate the clinical experience for everyone involved.

  8. Completed Clinical Trials Continued To Climb In 2024 6/19/2025

    Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.

  9. Time-To-Event Analysis In Oncology Through The Prism Of Estimands 7/23/2024

    Considering an ICH E9R(1) Addendum on Estimands and Sensitivity Analysis, several sensitivity analyses are now regarded as supplementary analyses. Learn about these changes and their effects oncology trials.

  10. Key Considerations Around Underrepresented Populations In Clinical Trials 9/18/2024

    Learn why increasing diversity and accessibility in clinical trials is crucial for equitable healthcare outcomes and how to address the barriers faced by underrepresented groups.